Conclusions
With advances in surgical techniques, with multimodalmultidisciplinary approach and with the use of total mesorectal excision we experienced a significant improvement in 5-year survival rate of patients with rectal cancer. However there still remains the question for truly optimal care for each patient with rectal cancer and his quality of life after surgical treatment.
In the first month after the surgery 2.25% (13) 
Results
• In the case of 573 (out of 578) patients (99.1%) we performed resection.
• R0 was achieved in 551 patients (96,1%).
• R1 was achieved in 8 patients (1,4%).
• R2 was achieved in 14 patients (2,4%).
• Postoperative mortality in the first month after the resection was performed was 9 (2,9%).
• 5-year survival rate of all patients surgically treated for rectal cancer was 231 (67,3%).
• From 578 patients who were operated on 29 (4,5%) had recurrences.
Methods
For analysis we used data gathered from:
• preoperative diagnostic tests, • reports gathered during operation, • reports from pathohistologic review • reports on complications after surgery • follow up
Distribution of patients based on resection

Location of tumors
Upper rectum -3,4% (15) Middle rectum -50,5% (223) Lower rectum -44,6% (197) No data -1,6% (7)
Background
• From 2004 to 2014, we operated on 578 patients who had been admitted for rectal cancer.
• We analyzed a variety of data to provide a summary of their survival rates. Clinical Rectal Cancer
ŠTEVILO ODSTOTEK
